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Abstract 
The epidermis is a self-renewing tissue homeostasis of which is dependent upon the 
tight balance between proliferation and differentiation based on appropriate regulation 
of the cell cycle. The cell cycle regulation is dependent on the interactions among a 
number of cell cycle regulatory molecules, including the pituitary tumor transforming 
gene 1 (PTTG1), also known as securin, a regulator of sister chromatid separation and 
transition from metaphase to anaphase. The present study was performed to clarify the 
little-known functions of PTTG1 in the epidermis by use of keratinocytes cultured 
under 2D or 3D conditions. Forced overexpression of PTTG1 caused upregulation of 
cyclin B1, CDK1, and c-Myc, resulting in enhanced proliferation and suppression of 
early differentiation without apparent alterations in terminal differentiation, and the 
exogenous PTTG1 was downregulated in association with cell cycle exit. In contrast, 
depletion of PTTG1 caused their downregulation and constrained proliferation with 
retention of differentiation capacity. These findings suggested that PTTG1 can alter the 
proliferation status by modulating the expression levels of the other cell cycle 
regulatory proteins, and excess PTTG1 primarily affects early differentiation of 
keratinocytes under the stability regulation associated with cell cycle exit.
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Introduction 
Proper regulation of cell proliferation and differentiation is critical for the maintenance 
of self-renewing tissues, such as the epidermis, a stratified epithelium consisting of 
keratinocytes. Within the epidermis, proliferation is principally confined to the basal 
layer and differentiation occurs as keratinocytes migrate through the suprabasal layers 
after growth arrest, namely, cell cycle exit (Fuchs and Horsley, 2008; Gandarillas et al., 
2000). When the balance leans toward proliferation and differentiation is suppressed, 
epidermal proliferative disorders occur, such as squamous cell carcinoma and psoriasis. 
This relationship relies on the interactions among the numerous cell cycle regulatory 
molecules, such as cyclins, cyclin-dependent kinases (CDK), CDK inhibitors, and 
transcription factors such as p53 (Di Cunto et al., 1998; Muller, 1995), which are known 
to alter keratinocyte proliferation and differentiation under several experimental settings 
(Di Cunto et al., 1998; Hauser et al., 2004; Truong et al., 2006; Watt et al., 2008; Wong 
et al., 2010).  
Pituitary tumor transforming gene 1 (PTTG1), initially identified as a protooncogene 
(Pei and Melmed, 1997) and later characterized as vertebrate securin (Zou et al., 1999), 
is expressed abundantly in multiple cancer cell types and its transforming activity has 
been demonstrated experimentally (Panguluri et al., 2008; Tong and Eigler, 2009). 
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PTTG1 possesses transcriptional activity in its C-terminal region and has several 
validated transcriptional targets, such as c-myc and basic fibroblast growth factor 
(bFGF). As a cell cycle regulatory protein, PTTG1 plays a role in the regulation of sister 
chromatid separation and transition from metaphase to anaphase, it functions as securin, 
and shows interactions with other cell cycle regulatory molecules, such as CDK1 
(Ramos-Morales et al., 2000), CDK inhibitor p21WAF1/Cip1 (Chesnokova et al., 2007), 
and p53 (Yu et al., 2000a). In normal tissue, PTTG1 expression is restricted and highly 
expressed in the testis in a stage-specific manner during spermatogenesis, suggesting 
that PTTG1 may play a role in male germ cell differentiation (Ramos-Morales, 2000; 
Pei, 1998). These observations indicate that PTTG1 has important functions in 
proliferation and differentiation. However, its physiological function in the epidermis 
remains to be elucidated. 
The present study was performed to investigate the role of PTTG1 in keratinocyte 
proliferation and differentiation using HaCaT cells, normal human keratinocytes (NHK), 
and neonatal murine keratinocytes (NMK) cultured under 2D or 3D conditions. PTTG1 
overexpression enhanced proliferation and upregulated the levels of cyclin B1, CDK1, 
and c-Myc expression at both protein and mRNA levels. Excess PTTG1 protein was 
downregulated in association with cell cycle exit and suppressed early differentiation 
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without significant alterations in terminal differentiation. These findings suggested that 
PTTG1 may maintain the proliferative phenotype in keratinocytes by delaying cell cycle 
exit.  
 
Results 
PTTG1 expression in normal keratinocytes is under cell cycle-dependent 
regulation 
The in vivo expression of PTTG1 in epidermal keratinocytes was confirmed by 
immunostaining of normal human skin with an antibody against PTTG1 protein. 
PTTG1 was shown to be expressed in the basal and peribasal keratinocytes, and was 
localized in the nucleus and cytoplasm (Fig. 1A). Some PTTG1-positive keratinocytes 
were not located in the basal layer but in the peribasal layer, indicating that some 
peribasal keratinocytes still possessed proliferative capacity and had not completed cell 
cycle exit, as reported previously (Bata-Csorgo et al., 1993; Dover and Watt, 1987; 
Penneys et al., 1970; Pinkus and Hunter, 1966; Regnier et al., 1986; Zanet et al., 2010). 
Next, NMK were cultured in low- or high-calcium-containing medium. NMK cultured 
under high-calcium conditions undergo a phenomenon known as calcium switch, which 
involves cell cycle exit followed by terminal differentiation (Rothnagel et al., 1993). 
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The results of immunoblotting and quantitative RT-PCR indicated significantly elevated 
PTTG1 expression in undifferentiated keratinocytes cultured under low-calcium 
conditions (0.05 mM calcium) at both the mRNA and protein levels in comparison to 
those cultured under high-calcium conditions (0.12 mM calcium) (Fig. 1B and C). 
Therefore, these findings indicated that PTTG1 is expressed at high levels during the 
cell cycle, and is downregulated after cell cycle exit. 
 
PTTG1 alters the thickness of epithelia formed by human keratinocytes cultured 
under 3D conditions 
HaCaT cells and NHK were cultured under 3D conditions as described in Materials and 
methods to allow experimental investigation of the effects of PTTG1 expression in 
epidermal keratinocytes. In this experimental model, the thickness of epithelium-like 
structures formed by stratified keratinocytes can demonstrate the proliferation capacity. 
They were transduced with a retroviral vector encoding rat PTTG1 and nerve growth 
factor receptor (NGFR) to establish cells with constitutive PTTG1 expression. The 
vector containing only the NGFR sequence was used as a control. Exogenous PTTG1 
expression was monitored at the protein level (Fig. 6-A). HaCaT cells and NHK were 
depleted of endogenous PTTG1 using a lentiviral vector encoding a short-hairpin RNA 
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(shRNA) against PTTG1, and a vector encoding scrambled shRNA sequence was used 
as a negative control. Sufficient knockdown was confirmed at the protein level (Fig. 
6-A). Constitutive PTTG1 expression resulted in the formation of thicker epidermoid 
epithelia than the control, whereas PTTG1 depletion resulted in the formation of thinner 
epithelia than the negative control (Fig. 2). These results suggested that PTTG1 altered 
the thickness of the epidermoid epithelia formed by human keratinocytes because of its 
crucial influence on keratinocyte proliferation. 
 
Overexpression of PTTG1 suppressed early differentiation of human keratinocytes 
cultured under 3D conditions 
Keratinocytes cultured under 3D conditions can mimic their differentiation pattern 
under physiological conditions (Bell et al., 1981). To analyze the effects of PTTG1 on 
the differentiation, immunostaining of 3D cultured HaCaT cells (A) and NHK (B) was 
performed using antibodies against early differentiation markers of keratinocytes, K1 
and K10, along with K14 and PTTG1. In addition, NHK were stained with an antibody 
against the terminal differentiation marker loricrin. Constitutive PTTG1 overexpression 
in HaCaT cells caused decreases in thickness of K1- and K10-positive layers and 
increases in thicknesses of undifferentiated layers (Fig. 3-A), whereas NHK showed an 
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increase in the undifferentiated layers although substantial changes in the stained layers 
correlated with the total thickness change (Fig. 3-B). There was no apparent change in 
staining pattern for loricrin (Fig. 3-B). On the other hand, PTTG1 depletion had no 
significant effect on the staining patterns of any of the differentiation markers despite 
the changes in the total layer thickness in both HaCaT cells and NHK (Fig. 3). These 
results suggested that excess PTTG1 suppresses early differentiation specifically, but 
the absence of PTTG1 had no significant effect on the differentiation of human 
keratinocytes. 
 
Overexpression of PTTG1 suppressed early keratinocyte differentiation under 2D 
conditions 
The results of the study using HaCaT cells and NHK suggested that PTTG1 may 
suppress early keratinocyte differentiation. To demonstrate its role in keratinocyte 
differentiation under another experimental setting, an expression plasmid encoding the 
rat PTTG1 was transfected into NMK. The cells were induced to undergo differentiation 
by calcium switch, allowing us to observe their two independent biological conditions 
separately: during the cell cycle or after cell cycle exit. Differentiating keratinocytes 
cultured under high-calcium conditions showed marked decreases in K1 and K10 
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expression at both the mRNA and protein levels (Fig. 4). These observations suggested 
that PTTG1 also suppressed early differentiation of normal keratinocytes under 2D 
conditions. 
 
PTTG1 altered keratinocyte proliferation patterns under both 2D and 3D 
conditions 
Proliferation and differentiation processes are generally independent of each other. To 
verify whether the suppressed keratinocyte differentiation described above was due to 
enhanced proliferation, we examined the effects of the change in PTTG1 expression 
level on keratinocyte proliferation pattern. First, we examined the proliferative capacity 
by counting the proliferation rate of HaCaT cells. PTTG1 overexpression resulted in 
increased proliferation rate, whereas depletion of PTTG1 resulted in a decrease in 
proliferation rate (Fig. 5-A). Next, immunostaining using an antibody against Ki67, a 
classic proliferation marker, was performed to confirm the proliferative status under 3D 
conditions. HaCaT cells and NHK overexpressing PTTG1 showed increased positivity 
for Ki67 (Fig. 5-B and C), whereas PTTG1-depleted keratinocytes showed decreased 
positivity (Fig. 5B and C). These results suggested that PTTG1 plays a critical role in 
maintaining proliferative capacity in HaCaT cells and NHK. 
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PTTG1-induced hyperproliferation is due to the upregulation of Cyclin B1, CDK1, 
and c-Myc oncoprotein 
As enhanced proliferation is related to faster progression of the cell cycle, we assayed 
the expression of endogenous cell cycle regulatory proteins by immunoblotting. HaCaT 
cells, NHK, and NMK overexpressing PTTG1 showed upregulation of cyclin B1, 
CDK1, and c-Myc (Fig. 6-A and -B). Cyclin B1, which is expressed in G2/M phase of 
the cell cycle, forms a complex also known as mitosis-promoting factor (MPF) with the 
master mitotic kinase CDK1 and promotes cell cycle progression. These upregulated 
cell cycle regulatory proteins may contribute to the more rapid cell cycle progression, 
resulting in enhancement of proliferation and delayed cell cycle exit, suppressing early 
differentiation. Moreover, the results of quantitative RT-PCR suggested that this 
upregulation was at the mRNA level (Fig. 6-C). In contrast, immunoblotting of 
PTTG1-depleted HaCaT cells and NHK revealed downregulation of these cell cycle 
regulatory proteins (Fig. 6). In addition, NHK overexpressing PTTG1 caused significant 
upregulation of Cyclin A, which is expressed in S/G2 phase of the cell cycle, and in 
contrast, PTTG1 depletion caused its downregulation (Fig. 6-A). However, there was no 
such change in the expression level of Cyclin D1, which is highly expressed in G1 
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phase of the cell cycle (Fig. 6-A). These observations suggested that PTTG1 may 
modulate the expression levels of these endogenous cell cycle regulatory proteins that 
are abundant in G2/M phase of the cell cycle. Notably, NMK overexpressing PTTG1 
cultured under high-calcium conditions showed markedly decreased expression of 
PTTG1 protein along with Cyclin B1 and CDK1, despite its constitutive expression as 
confirmed by the mRNA level (Fig. 6-C), indicating the stability regulation of the 
exogenous PTTG1 protein in association with cell cycle exit along with these 
upregulated proteins. 
  
Discussion 
In the epidermis, PTTG1 expression is confined to the proliferative layers, and 
undifferentiated NMK specifically showed PTTG1 mRNA and protein expression. 
These results indicated the cell cycle-dependent regulation of PTTG1 expression, as 
reported previously (Cohen-Fix et al., 1996; Funabiki et al., 1996; Ramos-Morales et al., 
2000; Yu et al., 2000b; Zou et al., 1999). In addition, we showed that constitutive 
PTTG1 overexpression caused upregulation of cyclin B1 and CDK1, which are known 
to form a complex also referred to as MPF. In contrast, PTTG1 depletion resulted in 
their downregulation, affecting cell cycle progression. 
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In the eukaryotic cell cycle, the tightly regulated expression and degradation of cell 
cycle regulatory proteins are indispensable, and degradation of these molecules is 
dependent on the ubiquitin – proteasome pathway (Ciechanover, 1998). In the G2/M 
phase of the cell cycle, securin (PTTG1) and cyclin B1 accumulate at the metaphase 
stage of mitosis followed by their rapid degradation, which promotes exit from mitosis 
(Clute and Pines, 1999; Hagting et al., 2002; Herbert et al., 2003; Peters, 2002; Zur and 
Brandeis, 2001). During this process, anaphase-promoting complex (APC), a ubiquitin 
ligase, mediates proteolysis by recognizing polyubiquitinization targets that will be 
subjected to degradation via the proteasome, leading to the periodic expression of these 
cell cycle regulatory proteins (King et al., 1995). A growing body of evidence suggests 
that PTTG1 expedites M phase progression via stabilization of cyclin B with its 
inhibitory effect on the APC activity, as demonstrated by experiments using murine 
oocytes (Marangos and Carroll, 2008) or budding yeast (Cohen-Fix and Koshland, 
1999; Tinker-Kulberg and Morgan, 1999). Thus, the results of the present study may 
illustrate the universal feature of PTTG1 protein regarding M phase regulation beyond 
the cell division patterns or biological classification. 
We also showed significant changes in the expression level of Cyclin A, which is 
predominantly expressed in S/G2 phase of the cell cycle with no such change in Cyclin 
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D1, a G1 phase cyclin, using NHK. These observations indicated that with regard to the 
effect on cell cycle progression, PTTG1 protein may have a greater influence on G2/M 
phase where it is abundantly expressed under physiological conditions (Ramos-Morales 
et al., 2000). A study using securin knockout cells, which showed elongation of the 
metaphase to anaphase interval in M phase without significant changes in other phases 
of the cell cycle (Jallepalli et al., 2001), may support our findings. In addition, we 
showed that exogenous PTTG1 protein was downregulated in calcium-induced 
differentiating NMK despite its constitutive overexpression, suggesting the existence of 
a stability regulation mechanism similar to the ubiquitin – proteasome pathway known 
to play a role in M phase regulation. Briefly, excess PTTG1 protein appears to enhance 
proliferation via upregulation of G2/M cell cycle accelerators, but once the 
keratinocytes exit the cell cycle and undergo differentiation, it may have little effect on 
later differentiation processes because of its own downregulation, which may be 
consistent with the staining pattern of loricrin without significant alterations in NHK 
overexpressing PTTG1 cultured under 3D conditions. This implies an important cell 
cycle regulatory machinery in keratinocyte differentiation. As demonstrated by the 
experiments involving culture under 3D conditions, absence of PTTG1 protein appeared 
not to disturb the differentiation capacity of keratinocytes. This is consistent with the 
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phenotype of PTTG knockout mice, which were viable and fertile but showed 
hypoplasia in multiple organs including the thymus, testis, and spleen, in which the 
levels of PTTG1 expression levels are high (Wang et al., 2001). In keratinocytes, 
PTTG1 can alter the proliferation status by modulating the expression levels of other 
cell cycle regulatory proteins, especially those expressed in G2/M phase of the cell 
cycle, but may have little effect on terminal differentiation itself. 
In conclusion, the results of the present study suggested that PTTG1 alters the 
proliferation status by modulating the expression levels of other cell cycle regulatory 
proteins, such as CyclinB1, CDK1, and c-Myc. This aberrant cell cycle regulation due 
to the overexpression of PTTG1 suggested that it may play important roles in 
hyperproliferative disorders in the epidermis, such as psoriasis or squamous cell 
carcinoma. In addition, the stable regulation of excess PTTG1 protein in association 
with cell cycle exit implies the existence of an important mechanism of cell cycle 
regulation involved in keratinocyte differentiation. 
 
Materials and methods 
 
Plasmids 
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The plasmid pBKCMV-PTTG1 encoding the full-length PTTG1 (NM_022391) was a 
kind gift from Dr. Songguang Ren (Cedars-Sinai Medical Center, Los Angeles, CA). 
The construct was confirmed by enzymatic digestion and sequenced to verify the correct 
reading frame before use. 
 
Cell culture 
HaCaT cells were maintained in MCDB153 growth medium (Sigma-Aldrich, St. Louis, 
MO) supplemented with 0.1 mM calcium chloride, 10 ng/mL EGF (Sigma-Aldrich), 1% 
penicillin–streptomycin solution (Sigma-Aldrich), and decalcified fetal bovine serum 
(Gibco-BRL, Paisley, UK) as described previously (Kato et al., 1995). Normal human 
keratinocytes (NHK) (KJB-100; DS Pharma, Osaka, Japan) were cultured in serum-free 
growth medium (KJB-200; DS Pharma) in accordance with the manufacturer’s 
instructions. Keratinocytes within fourth passage were used for the experiments. 
Primary mouse keratinocyte cultures were prepared as described previously (Rothnagel 
et al., 1993). Three-dimensional (3D) cell culture was performed as described 
previously (Taguchi et al., 2011). Briefly, human dermal fibroblasts (Kurabo, Osaka, 
Japan) were cultured in type I collagen gel (Cellmatrix type IA; Nitta Gelatin Inc., 
Osaka, Japan), in 12-well plates at a density of 3.0×105/well (HaCaT) or 5.0×105/well 
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(NHK). After solidification of the gels, HaCaT cells and NHK were seeded onto each 
well at densities of 1.3×105/well and 5.0×105/well, respectively. After incubation for 72 
h, the double-layered cultures were exposed to the air-liquid interface, underneath 
which the inverted cell strainers contained 3D medium consisting of a 1:1 mixture of 
MCBD153 medium (HaCaT) or KJB-200 medium (NHK) with Dulbecco’s Modified 
Eagle’s Medium (Wako, Osaka, Japan) supplemented with 10% decalcified FBS sand 
1% penicillin–streptomycin solution (Falcon, Franklin Lakes, NJ) in 6-well plates. The 
cultures in triplicate wells were analyzed on the indicated dates. The thicknesses of the 
epithelia formed were measured as described previously (Taguchi et al., 2011). 
DNA transfection 
Keratinocytes from newborn mice were transfected using TransIT®-Keratinocyte 
Transfection Reagent (Mirus Bio, Madison, WI). To examine mRNA or protein 
expression in undifferentiated keratinocytes, cells were cultured in 
low-calcium-containing medium for 48 h after transfection and then harvested. 
Expression in differentiated keratinocytes was assessed by cultivation for 24 h in 
low-calcium medium (0.05 mM calcium) without EGF, followed by 48 h in 
high-calcium medium (0.12 mM calcium). 
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Retroviral production and transduction 
cDNA encoding PTTG1 was digested from the plasmid and subcloned into the 
corresponding sites of the retroviral vector GCDNsap containing nerve growth factor 
receptor (NGFR) and transduced into the packaging cell line 293gpg along with the 
control vector encoding NGFR, as described previously (Fujisawa et al., 2009). The 
virus titers were approximately 1.0×105 infectious units/mL on Jurkat cells. 
The retroviral vectors were transduced into HaCaT cells or NHK cultured in 6-well 
plates and then subcultured into several dishes 10 cm in diameter. Flow cytometry was 
performed to detect successful transduction using a FACSCalibur™ (BD Biosciences, 
Franklin Lakes, NJ) and LNGFR-APC antibody (Miltenyi Biotec, Bergisch Gladbach). 
The efficacy of transduction was 80% – 90%. 
Immunoblotting 
Cells at 80% confluency in 10-cm culture dishes were solubilized using Sample Buffer 
Solution (Wako). The whole-cell lysates were subjected to sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) on Mini-PROTEAN® TGX™ 
Precast Gels (Bio-Rad, Hercules, CA), and the proteins were transferred onto 
nitrocellulose membranes (GE Healthcare, Buckinghamshire, UK). The membranes 
were incubated overnight with primary antibodies against PTTG1 (10 µg/mL; ab-3305; 
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ABcam, Cambridge, UK), keratin 10 (0.2 µg/mL; PRB-159P; Covance, Emeryville, 
CA), keratin 1 (0.2 µg/mL; PRB-165P; Covance), keratin 5 (0.2 µg/mL; PRB-160P; 
Covance), cyclin A (10 µg/mL RB-1548; Thermo Fisher Scientific, Newark, DE), cyclin 
B1 (0.5 µg/mL 05-373SP; Millipore, Billerica, MA), cyclin D1 (2 µg/mL; sc-718; Santa 
Cruz Biotechnology, Santa Cruz, CA), c-Myc (2 µg/mL; sc-40; Santa Cruz 
Biotechnology), β-actin (0.2 µg/mL; BioVision, Mountain View, CA), and CDK1 (1 
µg/mL; Millipore), followed by incubation for 60 min with HRP-labeled secondary 
antibodies against rabbit IgG (0.04 µg/mL; Santa Cruz) and mouse IgG (0.4 µg/mL; 
Santa Cruz). Antibody binding was visualized and enhanced with SuperSignal® West 
Pico Chemiluminescent Substrate (Thermo Fisher Scientific) and Hyperfilm™ MP (GE 
Healthcare). The intensities of the bands were quantified by densitometry, and the 
expression levels were normalized relative to β-actin. 
 
Immunohistochemical staining 
Sections of 3D cultures were treated by autoclaving in 10 mM citrate buffer (pH 6.0) for 
antigen retrieval and incubated overnight with primary antibodies against keratin 14 
(0.1 µg/mL; MS-115; Thermo Fisher Scientific), keratin 1 (0.5 µg/mL; PRB-149P; 
Covance), keratin 10 (100×; MON 3025; Sanbio B.V., Uden, The Netherlands), loricrin 
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(0.5 µg/mL; PRB-145P; Covance), and Ki67 (0.05 µg/mL; ab833; ABcam), followed by 
visualization using an EnVision™ kit according to the standard protocol (Dako, 
Glostrup, Denmark) and counterstaining with hematoxylin. 
 
Quantitative real-time PCR analysis 
Total RNA was extracted from 10-cm culture dishes at 80% – 90% confluency using 
ISOGEN® (Nippon Gene, Tokyo, Japan) and cDNA was synthesized using a Prime 
Script® RT reagent kit (Takara Bio, Shiga, Japan). An ABI PRISM® 7000 Sequence 
Detection System (Applied Biosystems, Foster City, CA) was used for SYBR® Green 
(Takara Bio)-based quantitative analysis. The quantity of mRNA was normalized 
relative to that of GAPDH. Quantification was performed in triplicate. The primers used 
were as follows: 
Keratin 10: (forward: 5'-CTGACAATGCCAACGTGCTG-3'; reverse: 
5'-GCAGGGTCACCTCATTCTCGTA-3') 
PTTG1 (mouse): (forward: 5'-TTTGGCATCTAAGGATGGGTTGA-3'; reverse: 
5'-AGCATTGAACACTTTGCCGACTC-3') 
PTTG1 (rat) (forward: 5'-GGCTTGCCTAAAGCCACCAG-3'; reverse: 
5'-GTAGGCATCATCAGGAGCAGGAG-3') 
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Cyclin B1 (forward: 5'-TGAGCCTGACCTGAACCTG-3'; reverse: 
5'-GTTTCCATCGGGCTTGGAGA-3') 
CDK1 (forward: 5'-ACTGGCTGATTTCGGCCTTG -3'; reverse: 
5'-CAGCAACACTTCTGGAGATCGGTA-3') 
c-Myc (forward: 5'-CCTAGTGCTGCATGAGGAG -3'; reverse: 
5'-GGATGGAGATGAGCCCGAC -3') 
GAPDH (forward: 5'-AAATGGTGAAGGTCGGTGTGAAC-3'; reverse 
5'-CAACAATCTCCACTTTGCACTG-3') 
 
Depletion of PTTG1 via shRNA 
Lentiviral particles encoding shRNA targeting PTTG1 mRNA were purchased from 
Santa Cruz Biotechnology (sc-37491-V). Lentiviral particles encoding a scrambled 
shRNA sequence (sc-108080) were also purchased from the same source for use as a 
control. HaCaT cells and NHK were transduced with these lentiviral particles in 
accordance with the manufacturer’s instructions, and the knockdown efficacy was 
assessed at the protein level by immunoblotting. 
 
Measurement of HaCaT cell proliferation rate 
 21 
HaCaT cells of each strain were seeded into 6-well plates at a density of 5×104 
cells/well in the growth medium described above. The next day, the medium was 
replaced with fresh medium, and the numbers of cells in triplicate wells were counted 
by trypsinization every 24 h, from 48 h to 120 h after seeding. 
 
Statistical analysis 
Data are expressed as means ± standard error of the mean (SEM). Comparisons among 
groups were performed with the paired Student’s t test. In all analyses, P < 0.05 was 
taken to indicate statistical significance. 
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Figure legends 
Figure 1 
PTTG1 expression in normal keratinocytes is under cell cycle-dependent 
regulation 
(a) Immunostaining of normal human skin with an antibody to PTTG1 protein. PTTG1 
was expressed in basal and peribasal keratinocytes, and localized in the cytoplasm and 
nucleus. Bar = 100μm (b) Total RNAs extracted from neonatal murine keratinocytes 
(NMK) cultured in low- or high-calcium-containing medium were subjected to 
quantitative real-time PCR. Relative expression of PTTG1 (left) and K10 (right) mRNA 
in NMK under low- and high-calcium conditions. PTTG1 mRNA expression level was 
6.6-fold higher under low-calcium conditions than under high-calcium conditions. The 
results indicated cell cycle-dependent transcriptional regulation of PTTG1. The 
expression levels were normalized relative to GAPDH mRNA expression. All values 
represent means ± SEM from three independent experiments. **P < 0.01. (c) 
Immunoblotting of whole-cell extracts from NMK cultured under low- or high-calcium 
conditions. PTTG1 protein expression became almost undetectable as NMK underwent 
differentiation, also indicating cell cycle-dependent regulation. 
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Figure 2 
PTTG1 altered the thickness of epithelia formed by human keratinocytes cultured 
under 3D conditions 
(a) (b) HaCaT cells were transduced with a retroviral vector encoding rat PTTG1 and 
nerve growth factor receptor (NGFR) and endogenous PTTG1 was depleted from 
HaCaT cells using a lentiviral vector encoding shRNA against PTTG1. PTTG1 
expression and sufficient knockdown were monitored by immunoblotting (see Fig. 6–a). 
Constitutive PTTG1 expression resulted in formation of thicker epidermoid epithelia 
than the control, whereas absence of endogenous PTTG1 in HaCaT cells resulted in 
formation of thinner epithelia: epidermoid epithelia formed 10 days after exposure to 
the air-liquid interface (hematoxylin-eosin staining) Bar = 20μm (a); temporal 
thickness measurement of the epithelia (b). 
(c) (d) NHK were transduced with the PTTG- or sh-RNA-encoding retroviral vectors 
and cultured under 3D conditions as were HaCaT cells. Successful PTTG1 
overexpression or endogenous PTTG1 knockdown was monitored by immunoblotting 
(see Fig. 6-b). PTTG1 expression resulted in formation of thicker epidermoid epithelia 
than the control, whereas absence of endogenous PTTG1 NHK resulted in formation of 
thinner epithelia: epidermoid epithelia formed 4 days after exposure to the air-liquid 
 24 
interface (hematoxylin-eosin staining) Bar = 20μm (a); thickness measurement of the 
epithelia (b). 
All values represent means ± SEM from three independent experiments **P < 0.01 vs. 
control. 
 
Figure 3 
Overexpression of PTTG1 suppressed early differentiation of human keratinocytes 
cultured under 3D conditions 
Representative figure of HaCaT cells and NHK cultured under 3D conditions stained 
with antibodies against K1 and K10 (keratinocyte early differentiation markers), along 
with K14 and PTTG1. NHK was also stained with an antibody against loricrin (a 
terminal keratinocyte differentiation marker).  
(a) Constitutive PTTG1 overexpression in HaCaT cells caused decreases in thickness of 
K1- and K10-positive layers and increases in thicknesses of undifferentiated layers.  
(b) Constitutive PTTG1 overexpression in NHK was associated with an increase in the 
undifferentiated layers although substantial changes in the stained layers were 
correlated with the total thickness. There was no apparent change in loricrin staining 
pattern. Note the bottom-heavy staining pattern of PTTG1 despite its constitutive 
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overexpression. 
(a) (b) PTTG1 depletion had no significant effect on staining patterns of any of the 
differentiation markers despite the changes in total layer thickness. Bars = (a) 20μm; 
(b) 50μm. 
Figure 4 
Overexpression of PTTG1 suppressed early keratinocyte differentiation under 2D 
conditions 
NMK were transfected with an expression plasmid encoding PTTG1 and induced to 
differentiate by calcium switch. 
(a) Representative results of immunoblotting of whole-cell lysate from differentiating 
NMK cultured under high-calcium conditions. NMK constitutively overexpressing 
PTTG1 showed decreases in K1 and K10 compared with NMK transfected with pCMV 
empty vector. The band intensities quantified by densitometry were significantly 
different. The expression levels were normalized relative to β-actin. 
(b) Total RNAs extracted from NMK were subjected to quantitative real-time PCR. 
Relative expression levels of K1, K10, and PTTG1 mRNA. NMK constitutively 
expressing PTTG1 showed decreases in K1 and K10 compared with NMK transfected 
with pCMV empty vector. The expression levels were normalized relative to GAPDH 
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mRNA expression.  
(a) (b) The exogenous PTTG1 protein was downregulated under high-calcium 
conditions despite its constitutive expression as confirmed by detection of its mRNA. 
All data are means ± SEM form three independent experiments. **P < 0.01 vs. control; 
n.s. not significant. 
 
Figure 5 
PTTG1 altered keratinocyte proliferation patterns under both 2D and 3D 
conditions 
(a) Proliferation rate was assayed by cell counting. HaCaT cells constitutively 
expressing PTTG1 showed increased proliferation rate compared with controls, whereas 
PTTG1-depleted HaCaT cells showed a decreased proliferation rate. 
(b) (c) HaCaT cells (b) and NHK (c) cultured under 3D conditions were stained with an 
antibody against Ki67. Constitutive expression of PTTG1 resulted in an increase in 
number of Ki67-positive cells, whereas depletion of PTTG1 resulted in a decrease. All 
values represent means ± SEM from three independent experiments. **P < 0.01 vs. 
control. Bars = (a) 20μm; (b) 50μm 
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Figure 6 
PTTG1-induced keratinocyte hyperproliferation is due to the upregulation of 
Cyclin B1, CDK1 and c-Myc oncoprotein 
(a), (b) Representative immunoblotting of whole-cell lysates from HaCaT cells, NHK, 
and NMK. Cyclin B1, CDK1, and c-Myc were upregulated due to constitutive 
expression of PTTG1, whereas all of these molecules were downregulated due to 
depletion of PTTG1. The band intensities quantified by densitometry showed significant 
differences (graphs). Expression levels of Cyclin A (S/G2 phase cyclin) and Cyclin D1 
(G1 phase cyclin) in NHK were analyzed by immunoblotting. Compared with Cyclin 
D1, Cyclin A expression level changed significantly according to PTTG1 expression 
level, showing similarity to PTTG1, Cyclin B1, and CDK1. The expression levels were 
normalized relative to β-actin. 
(c) Total RNAs extracted from NMK were subjected to quantitative real-time PCR. 
Relative expression levels of PTTG1, Cyclin B1, CDK1, and c-Myc mRNA. NMK 
constitutively expressing PTTG1 showed upregulation of these molecules. The 
expression levels were normalized relative to GAPDH mRNA expression. PTTG1 
protein was downregulated along with Cyclin B1 and CDK1 despite constitutive mRNA 
expression. 
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All data are means ± SEM form three independent experiments. **P < 0.01 vs. control; 
n.s. not significant. 
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